Publication details

Zpráva o průběhu klinického hodnocení KDO_DC1311 (EudraCT č. 2014-003388-39) za období od 10.09.2021 do 09.09.2022

Title in English Annual report about the clinical trial KDO_DC1311 (EudraCT No. 2014-003388-39) for the period from 10 Sept 2021 to 09 Sept 2022
Authors

DEMLOVÁ Regina KUBÁTOVÁ Jana

Year of publication 2022
MU Faculty or unit

Faculty of Medicine

Web KDO_DC1311
Description The annual report gives the overview of the conduct of the clinical trial „Combined antitumor therapy with ex vivo manipulated dendritic cells producing interleukin-12 in children, adolescents and young adults with progressive, recurrent or primarily metastatic high-risk tumors“. The primary aim of the clinical trial is to study the safety of inovative medicinal product of somatic cell therapy. Masaryk University is the trial sponsor.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info